LYME DISEASE
Clinical trials for LYME DISEASE explained in plain language.
Never miss a new study
Get alerted when new LYME DISEASE trials appear
Sign up with your email to follow new studies for LYME DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pfizer's lyme vaccine nears finish line in massive global trial
⭐️ VACCINE ⭐️ OngoingThis study tests an experimental Lyme disease vaccine (VLA15) in about 12,500 healthy people aged 5 and older living in areas with high Lyme disease risk. Participants receive either the vaccine or a placebo, and researchers track how many get Lyme disease over up to 3.5 years. T…
Matched conditions: LYME DISEASE
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated May 07, 2026 18:41 UTC
-
Pfizer's lyme vaccine moves to final testing phase
⭐️ VACCINE ⭐️ OngoingThis study tests a new Lyme disease vaccine (VLA15) in healthy adults aged 18 to 44. Participants receive five shots over two years—four of the vaccine and one placebo—to see if different timing schedules are safe and produce a strong immune response. The goal is to find the best…
Matched conditions: LYME DISEASE
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated May 01, 2026 15:58 UTC